Insecticides (India) Limited — PPTs, 11-11-2024: Investor Presentation

**Financial Highlights:**

In Q2 FY25, Insecticides (India) reported a revenue of ₹627.1 crore, down 10% YoY, while H1 FY25 revenue reached ₹1,283.8 crore, reflecting a 4% decline. Improved profitability led to EBITDA margins rising to 14.3%, up from 11.8% in Q2 FY24, with EBITDA at ₹89.6 crore. Net profit for Q2 was ₹61.5 crore, marking a 16% increase YoY.

**Strategic Initiatives and Growth Drivers:**

The company is prioritizing premium product lines, which now represent 68% of B2C sales. The launch of the innovative herbicide, Torry Super, is poised to drive further growth in the maize market, especially in southern and western India.

**Business Developments:**

In a notable move, the company executed a buyback of 5 lakh equity shares at ₹1,000 each, totaling ₹50 crore, signaling strong cash flow and commitment to shareholder returns.

**Market Position and Competitive Advantage:**

Despite facing challenges from unpredictable weather impacting the spraying season, the industry's outlook is promising due to above-normal monsoon predictions, which may spur agrochemical demand.

**Investor Implications:**

Investors should be encouraged by the company’s enhanced focus on premiumization and its robust response to market demands. The trend towards sustainable agricultural solutions and innovative product launches supports a **positive outlook** for growth.